Document Detail


Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
MedLine Citation:
PMID:  16509865     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The purpose of this prospective study was to investigate whether amphotericin B (AmB) had any potential role in the systemic chemotherapy of primary hepatic malignancy using cancer cells collected by the authors' method of primary culture. METHODS: The specimens obtained by ultrasound-guided fine-needle aspiration biopsy (22 G) from 15 patients with hepatocellular carcinoma (HCC) and one with cholangiocarcinoma were plated into culture flask without disaggregation by trypsin-ethylenediamine tetra-acetic acid solution. Six patients with HCC and one patient with cholangiocarcinoma (7/16, 44%) had successful culture and the cancer cells at the 4th passage were continuously exposed to therapeutic ranges of epirubicin (0, 0.5, 1.0, 1.5, 2.0 microg/mL) with or without the combination of 2.5 microg/mL AmB for 24 h. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was applied to evaluate the effects of the drugs. A human HCC cell line (HA 22T/VGH) was studied for comparison. RESULTS: Addition of AmB showed no influence on epirubicin cytotoxicity in two patients (one partial resistant HCC and one epirubicin-sensitive cholangiocarcinoma; 25%), augmentation of the epirubicin cytotoxicity in two patients (one total resistant HCC, partial resistant HA 22T/VGH cell line and one epirubicin-sensitive HCC; 37.5%), and decrease of epirubicin cytotoxicity in the remaining three (one partial resistant and two epirubicin-sensitive HCC; 37.5%). CONCLUSIONS: Amphotericin B has a discordant influence on epirubicin cytotoxicity in primary cultured hepatic malignant cells. Application of AmB in the systemic chemotherapy of primary hepatic malignancy should be limited to patients with positive AmB effect evaluated by an in vitro sensitivity test such as the present method.
Authors:
Zu-Yau Lin; Wan-Long Chuang; Yen-Hwang Chuang; Ming-Lung Yu; Ming-Yuh Hsieh; Liang-Yen Wang; Jung-Fa Tsai
Related Documents :
3163975 - Effects of verapamil on uptake and in vitro toxicity of anthracyclines in human leukemi...
19789475 - An in vitro evaluation of the cell toxicity of honey and silver dressings.
3813485 - Different techniques for drug cytotoxicity evaluation on mcf-7 human breast cancer cell...
9531985 - Cytotoxic substances produced by a fungal strain from a sponge: physico-chemical proper...
21426555 - Antifoam addition to shake flask cultures of recombinant pichia pastoris increases yield.
217015 - Corticotropin, lipotropin, and beta-endorphin production by a human nonpituitary tumor ...
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of gastroenterology and hepatology     Volume:  21     ISSN:  0815-9319     ISO Abbreviation:  J. Gastroenterol. Hepatol.     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-03-02     Completed Date:  2006-08-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8607909     Medline TA:  J Gastroenterol Hepatol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  398-405     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine and Neurology, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan. linzuyau@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Amphotericin B / therapeutic use*
Anti-Bacterial Agents / therapeutic use*
Antibiotics, Antineoplastic / adverse effects*,  therapeutic use
Bile Duct Neoplasms / drug therapy,  pathology
Bile Ducts, Intrahepatic
Biopsy, Fine-Needle
Carcinoma, Hepatocellular / drug therapy,  pathology
Cell Culture Techniques
Cell Proliferation / drug effects
Cholangiocarcinoma / drug therapy,  pathology
Drug Interactions
Drug Therapy, Combination
Epirubicin / adverse effects*,  therapeutic use
Female
Follow-Up Studies
Humans
Liver Neoplasms / drug therapy,  pathology*
Male
Middle Aged
Prospective Studies
Treatment Outcome
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Antibiotics, Antineoplastic; 1397-89-3/Amphotericin B; 56420-45-2/Epirubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is there ileopathy in portal hypertension?
Next Document:  Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels w...